Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PPME1 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PPME1 mRNA | CTD | PMID:22079256 | PPME1 | Human | 1,2-dichloroethane | decreases expression | ISO | Ppme1 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of PPME1 mRNA | CTD | PMID:28960355 | PPME1 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Ppme1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of PPME1 mRNA | CTD | PMID:22206623 | PPME1 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Ppme1 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of PPME1 mRNA] | CTD | PMID:22206623 | PPME1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ppme1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPME1 mRNA | CTD | PMID:21215274 | PPME1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Ppme1 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PPME1 mRNA | CTD | PMID:25975270 | PPME1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ppme1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PPME1 mRNA | CTD | PMID:21570461 and PMID:24680724 | PPME1 | Human | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Ppme1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of PPME1 mRNA | CTD | PMID:20188158 | PPME1 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of PPME1 protein | CTD | PMID:34186270 | PPME1 | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Ppme1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PPME1 mRNA | CTD | PMID:36041667 | PPME1 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Ppme1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of PPME1 mRNA | CTD | PMID:30047161 | PPME1 | Human | amitrole | increases expression | ISO | Ppme1 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of PPME1 mRNA | CTD | PMID:30047161 | PPME1 | Human | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of PPME1 mRNA and Arsenic Trioxide results in increased expression of PPME1 protein | CTD | PMID:20458559 and PMID:25419056 | PPME1 | Human | benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of PPME1 mRNA | CTD | PMID:19162166 | PPME1 | Human | benzo[e]pyrene | decreases methylation | EXP | | 6480464 | benzo(e)pyrene results in decreased methylation of PPME1 intron | CTD | PMID:30157460 | PPME1 | Human | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of PPME1 gene | CTD | PMID:22576693 | PPME1 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PPME1 protein | CTD | PMID:34186270 | PPME1 | Human | bisphenol A | multiple interactions | ISO | Ppme1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PPME1 mRNA | CTD | PMID:36041667 | PPME1 | Human | bisphenol A | increases methylation | ISO | Ppme1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of PPME1 gene | CTD | PMID:28505145 | PPME1 | Human | bisphenol A | increases expression | ISO | Ppme1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of PPME1 mRNA | CTD | PMID:25181051 | PPME1 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PPME1 mRNA | CTD | PMID:22576693 | PPME1 | Human | Bisphenol B | increases expression | EXP | | 6480464 | bisphenol B results in increased expression of PPME1 protein | CTD | PMID:34186270 | PPME1 | Human | bisphenol F | multiple interactions | ISO | Ppme1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PPME1 mRNA | CTD | PMID:36041667 | PPME1 | Human | Brodifacoum | increases expression | ISO | Ppme1 (Rattus norvegicus) | 6480464 | bromfenacoum results in increased expression of PPME1 protein | CTD | PMID:28903499 | PPME1 | Human | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of PPME1 mRNA | CTD | PMID:26079696 | PPME1 | Human | cadmium dichloride | decreases expression | ISO | Ppme1 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased expression of PPME1 mRNA | CTD | PMID:33453195 | PPME1 | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of PPME1 protein | CTD | PMID:35688186 | PPME1 | Human | cannabidiol | multiple interactions | EXP | | 6480464 | [Cuprizone co-treated with Cannabidiol] results in decreased expression of PPME1 protein | CTD | PMID:34122009 | PPME1 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to PPME1 gene] | CTD | PMID:28238834 | PPME1 | Human | chlorpyrifos | increases expression | ISO | Ppme1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of PPME1 mRNA | CTD | PMID:37019170 | PPME1 | Human | chromium(6+) | affects expression | EXP | | 6480464 | chromium hexavalent ion affects the expression of PPME1 mRNA | CTD | PMID:30690063 | PPME1 | Human | clobetasol | increases expression | ISO | Ppme1 (Mus musculus) | 6480464 | Clobetasol results in increased expression of PPME1 mRNA | CTD | PMID:27462272 | PPME1 | Human | Cuprizon | multiple interactions | EXP | | 6480464 | [Cuprizone co-treated with Cannabidiol] results in decreased expression of PPME1 protein | CTD | PMID:34122009 | PPME1 | Human | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of PPME1 mRNA and Arsenic Trioxide results in increased expression of PPME1 protein | CTD | PMID:20458559 and PMID:25419056 | PPME1 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of PPME1 mRNA | CTD | PMID:28302478 | PPME1 | Human | dioxygen | multiple interactions | ISO | Ppme1 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPME1 mRNA | CTD | PMID:30529165 | PPME1 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPME1 mRNA | CTD | PMID:27188386 | PPME1 | Human | elemental selenium | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of PPME1 mRNA | CTD | PMID:19244175 | PPME1 | Human | elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of PPME1 mRNA | CTD | PMID:19244175 | PPME1 | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PPME1 protein | CTD | PMID:23301498 | PPME1 | Human | ethanol | multiple interactions | ISO | Ppme1 (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of PPME1 mRNA | CTD | PMID:30319688 | PPME1 | Human | fenthion | decreases expression | ISO | Ppme1 (Mus musculus) | 6480464 | Fenthion results in decreased expression of PPME1 mRNA | CTD | PMID:34813904 | PPME1 | Human | folic acid | multiple interactions | ISO | Ppme1 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of PPME1 mRNA] | CTD | PMID:22206623 | PPME1 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of PPME1 protein | CTD | PMID:37730182 | PPME1 | Human | gentamycin | increases expression | ISO | Ppme1 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of PPME1 mRNA | CTD | PMID:33387578 | PPME1 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of PPME1 protein | CTD | PMID:32959892 | PPME1 | Human | methapyrilene | decreases methylation | EXP | | 6480464 | Methapyrilene results in decreased methylation of PPME1 intron | CTD | PMID:30157460 | PPME1 | Human | methidathion | decreases expression | ISO | Ppme1 (Mus musculus) | 6480464 | methidathion results in decreased expression of PPME1 mRNA | CTD | PMID:34813904 | PPME1 | Human | methimazole | increases expression | ISO | Ppme1 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of PPME1 mRNA | CTD | PMID:30047161 | PPME1 | Human | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of PPME1 mRNA | CTD | PMID:28001369 | PPME1 | Human | Morroniside | multiple interactions | EXP | | 6480464 | morroniside inhibits the reaction [Okadaic Acid results in increased expression of PPME1 protein] | CTD | PMID:26836014 | PPME1 | Human | okadaic acid | multiple interactions | EXP | | 6480464 | morroniside inhibits the reaction [Okadaic Acid results in increased expression of PPME1 protein] | CTD | PMID:26836014 | PPME1 | Human | okadaic acid | increases expression | EXP | | 6480464 | Okadaic Acid results in increased expression of PPME1 protein | CTD | PMID:26836014 | PPME1 | Human | p-toluidine | decreases expression | ISO | Ppme1 (Rattus norvegicus) | 6480464 | 4-toluidine results in decreased expression of PPME1 mRNA | CTD | PMID:27638505 | PPME1 | Human | paracetamol | affects expression | ISO | Ppme1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of PPME1 mRNA | CTD | PMID:17562736 | PPME1 | Human | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of PPME1 mRNA | CTD | PMID:26272509 | PPME1 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPME1 mRNA | CTD | PMID:27188386 | PPME1 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of PPME1 mRNA | CTD | PMID:22079256 | PPME1 | Human | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of PPME1 mRNA | CTD | PMID:22714537 | PPME1 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PPME1 mRNA | CTD | PMID:22079256 | PPME1 | Human | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Ppme1 (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of PPME1 mRNA | CTD | PMID:30047161 | PPME1 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 | PPME1 | Human | selenium atom | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of PPME1 mRNA | CTD | PMID:19244175 | PPME1 | Human | selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of PPME1 mRNA | CTD | PMID:19244175 | PPME1 | Human | sodium arsenite | multiple interactions | EXP | | 6480464 | sodium arsenite deficiency promotes the reaction [sodium arsenite results in increased expression of PPME1 mRNA] | CTD | PMID:28336213 | PPME1 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of PPME1 mRNA | CTD | PMID:28336213 | PPME1 | Human | sodium arsenite | increases methylation | EXP | | 6480464 | sodium arsenite results in increased methylation of PPME1 promoter | CTD | PMID:28336213 | PPME1 | Human | sulfadimethoxine | increases expression | ISO | Ppme1 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of PPME1 mRNA | CTD | PMID:30047161 | PPME1 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of PPME1 mRNA | CTD | PMID:31758290 | PPME1 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of PPME1 mRNA | CTD | PMID:28818685 | PPME1 | Human | valproic acid | affects expression | ISO | Ppme1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of PPME1 mRNA | CTD | PMID:17292431 | PPME1 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of PPME1 mRNA | CTD | PMID:23179753 | PPME1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of PPME1 mRNA | CTD | PMID:25979313 | PPME1 | Human | vitamin E | increases expression | EXP | | 6480464 | Vitamin E results in increased expression of PPME1 mRNA | CTD | PMID:19244175 | PPME1 | Human | vitamin E | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of PPME1 mRNA | CTD | PMID:19244175 | |